Is GERN Worth Buying in 2026?

Geron Corp

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-07-26

Here’s whether Geron Corp (GERN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Neutral.

🔵
Neutral

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); RSI 48 — healthy momentum range; strong 1-year return of +10.9%. Concerns: 50-day MA is falling (-1.25% over 10 days); 3-month momentum negative (-5.3%); declining volume on rally — weak conviction (0.50x 30d avg). Currently 29.4% off its 52-week high. Score: +2/7.

Ready to act on this? 📈 Trade on Webull

GERN is in a confirmed uptrend, trading above both its 50-day ($1.31) and 200-day ($1.40) moving averages. An RSI of 47.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +10.9% compares to +16.5% for SPY (trailed the market by 5.5%). The current 29.4% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $11,094 today
vs. S&P 500 (SPY) — same period trailed market by 5.5%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($1.40)
Above 50-day MA ($1.31)
RSI(14) neutral zone (30–70) — currently 47.8
Positive return (+10.9%)
!Within 10% of period high (−29.4%)
Period Range $1.42
$1.04 $2.01
RSI (14) 47.8
0 · OversoldOverbought · 100

Key Metrics

Price$1.42
Period Return+10.9%
Period High$2.01
Period Low$1.04
Drawdown−29.4%
MA-50$1.31
MA-200$1.40
RSI (14)47.8
Avg Volume (30d)12.0M
vs. SPYtrailed by 5.5%
Return Rank#431 of 999

Trade GERN

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers